Passing the Torch. by Grant McFadden

Get full text

PLoS Pathogens at three years. by Kasturi Haldar, Grant McFadden

Get full text

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy by Masmudur M. Rahman, Grant McFadden

Get full text

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways by Masmudur M. Rahman, Grant McFadden

Get full text

Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN‐Induced Antiviral State in a  Highly Species‐Specific Fashion by Masmudur M. Rahman, Grant McFadden

Get full text

Modulation of tumor necrosis factor by microbial pathogens. by Masmudur M Rahman, Grant McFadden

Get full text

“Pearls”: A New Type of Open-Access Educational Resource by Hiten D. Madhani, Kasturi Haldar, Grant McFadden

Get full text

Change in the editorial leadership of PLoS Pathogens. by Kasturi Haldar, Grant McFadden, John A T Young

Get full text

Oncolytic Viruses and the Immune System: The Dynamic Duo by Ana Lemos de Matos, Lina S. Franco, Grant McFadden

Get full text

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses by Anne Everts, Melissa Bergeman, Grant McFadden, Vera Kemp

Get full text

When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond by Nissin Moussatché,1,2 Clarissa R. Damaso,2 and Grant McFadden1

Get full text

Advances in oncolytic virotherapy by Stephen J. Russell, John C. Bell, Christine E. Engeland, Grant McFadden

Get full text

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells. by Eric Bartee, Amy Meacham, Elizabeth Wise, Christopher R Cogle, Grant McFadden

Get full text

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies by Nancy Y. Villa, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle

Get full text

Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication. by Masmudur M Rahman, Jia Liu, Winnie M Chan, Stefan Rothenburg, Grant McFadden

Get full text

Viral SERPINS—A Family of Highly Potent Immune-Modulating Therapeutic Proteins by Kyle Varkoly, Roxana Beladi, Mostafa Hamada, Grant McFadden, James Irving, Alexandra R. Lucas

Get full text

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma by Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, Wojciech Fidyk, Ewa Chmielik, Masmudur M. Rahman, Grant McFadden

Get full text

The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. by Bérengère Boutard, Sophie Vankerckhove, Nicolas Markine-Goriaynoff, Mickaël Sarlet, Daniel Desmecht, Grant McFadden, Alain Vanderplasschen, Laurent Gillet

Get full text

Coinfections of Novel Polyomavirus, Anelloviruses and a Recombinant Strain of Myxoma Virus-MYXV-Tol Identified in Iberian Hares by Ana Águeda-Pinto, Simona Kraberger, Michael C. Lund, Christian Gortázar, Grant McFadden, Arvind Varsani, Pedro J. Esteves

Get full text

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase by Yanghee Woo, Susanne G Warner, Rula Geha, Marianne M Stanford, Penelope Decarolis, Masmudur M Rahman, Samuel Singer, Grant McFadden, Yuman Fong

Get full text